Award
Food and Drug Administration 5R01FD007632-04
ACCELERATE: An Efficient and Innovative Natural History Study Addressing Unmet Needs in Castleman Disease
Recipient
Not specified
Award Amount
$397,605.00
Ceiling
$397,605.00
Awarded
July 21, 2025
Identifier
5R01FD007632-04
Research grant awarded by the FDA for a natural history study on Castleman disease to identify patient subtypes and treatment approaches.
Description
This is a research grant opportunity related to a natural history study of Castleman disease, funded by the FDA, with a project period from September 1, 2025, to August 31, 2026. The project aims to leverage data collected from a previous collaborative study to identify patient subtypes and treatment approaches.